<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>&#43;mRNA on Vishvas&#39;s notes</title>
    <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/</link>
    <description>Recent content in &#43;mRNA on Vishvas&#39;s notes</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <atom:link href="https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Curevac</title>
      <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/curevac/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/curevac/</guid>
      <description>&lt;h2 id=&#34;efficacy&#34;&gt;Efficacy&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;47% efficacy. (40,000 volunteers in Latin America and Europe)&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;advantages&#34;&gt;Advantages&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;keeping stable for months in a refrigerator.&lt;/li&gt;&#xA;&lt;/ul&gt;</description>
    </item>
    <item>
      <title>Moderna vaccine</title>
      <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/Moderna_vaccine/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/Moderna_vaccine/</guid>
      <description>&lt;ul&gt;&#xA;&lt;li&gt;Synthetic mRNA-1273 for spike protein.&lt;/li&gt;&#xA;&lt;li&gt;Storage: -20 Deg up to 6 months&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;efficacy&#34;&gt;Efficacy&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;94.1% efficacy.&lt;/li&gt;&#xA;&lt;li&gt;Shown effective about 40 days after injection.&lt;/li&gt;&#xA;&lt;li&gt;It is not doing much to reduce the asymptomatic ones. The mRNA vaccines give good robust antibodies but not the IgA antibodies coating the nasal passages.So,you still carry viruses and keep spreading.&lt;/li&gt;&#xA;&lt;li&gt;Both the Pfizer and Moderna vaccines are 10 times less effective against the South African variant&lt;/li&gt;&#xA;&lt;/ul&gt;</description>
    </item>
    <item>
      <title>Pfizer-BioNTech</title>
      <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/Pfizer-BioNTech/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/mRNA/Pfizer-BioNTech/</guid>
      <description>&lt;ul&gt;&#xA;&lt;li&gt;An mRNA vaccine&lt;/li&gt;&#xA;&lt;li&gt;Storage requirement at -70 C&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;efficacy&#34;&gt;Efficacy&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;≥14 days after a single dose:       42%&lt;/li&gt;&#xA;&lt;li&gt;≥7 days after the second dose:    86%&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Reduces mild/ severe cases by 95% 7 days after 2nd dose of vaccine; reduces infection by 90%. 100% efficacy in adolescents&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;91.3% efficacy even after 6 months.&lt;/li&gt;&#xA;&lt;li&gt;Immune response after mRNA vaccinations after 2 doses demonstrated good and safe antibodies 8 weeks later. The efficacy against mutants was slightly reduced.&lt;/li&gt;&#xA;&lt;li&gt;Both the Pfizer and Moderna vaccines are 10 times less effective against the South African variant&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 id=&#34;b-1617&#34;&gt;B 1.617&lt;/h3&gt;&#xA;&lt;h4 id=&#34;symptomatic-disease&#34;&gt;Symptomatic disease&lt;/h4&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;After 1st dose     33.2%&lt;/li&gt;&#xA;&lt;li&gt;After  2nd dose    87.9%  effectiveness.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h4 id=&#34;hospitalization&#34;&gt;Hospitalization&lt;/h4&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;2 doses - 96% effective&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;severe-adverse-reactions&#34;&gt;Severe Adverse reactions&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;The exclusion criteria that was used during Pfizer vaccine trial included people with allergies. Bang on, on the field, exactly same happened. 2 healthcare professionals in the UK had anaphylactic reaction. Now the health regulators have adviced those having similar allergies or anaphylaxis should not get this vaccine.&lt;/li&gt;&#xA;&lt;li&gt;Pfizer vaccine volunteers got Bell&amp;rsquo;s palsy(4 of them)&lt;/li&gt;&#xA;&lt;li&gt;Low platelet count called Immune thrombocytopenia following Pfizer/Moderna vaccine administration are getting reported in the USA in small numbers.&lt;/li&gt;&#xA;&lt;li&gt;Till date,66 cases out of ~18 million vaccinations (=0.00000003%) had such reactions. All but 1 within 11 minutes. No deaths at all.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;price&#34;&gt;Price&lt;/h2&gt;&#xA;&lt;p&gt;It costs Pfizer $3 for a vial to manufacture but they are selling it to the rest of the world for $ 15-40,that is 5 to 13 times profit per dose!&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
